You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PARAFLEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Paraflex, and when can generic versions of Paraflex launch?

Paraflex is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.

The generic ingredient in PARAFLEX is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Paraflex

A generic version of PARAFLEX was approved as chlorzoxazone by AUROBINDO PHARMA LTD on May 4th, 1988.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PARAFLEX?
  • What are the global sales for PARAFLEX?
  • What is Average Wholesale Price for PARAFLEX?
Summary for PARAFLEX
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 137
Patent Applications: 3,588
DailyMed Link:PARAFLEX at DailyMed
Drug patent expirations by year for PARAFLEX

US Patents and Regulatory Information for PARAFLEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm PARAFLEX chlorzoxazone TABLET;ORAL 011300-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.